Project Grant K99DK140517
- Federal Grant Award Summary The University of Pennsylvania received a $1.2 million Project Grant from the National Center for Advancing Translational Sciences (NCATS, CFDA 93.350) awarded July 1, 2025, and scheduled for completion June 30, 2027. This grant funds a trial readiness initiative focused on LCAT (Lecithin-Cholesterol Acyltransferase) deficiency, an ultra-rare autosomal recessive genetic disorder manifesting as Familial LCAT Deficiency (FLD) or Fish-Eye Disease (FED). The project...
- This Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) is providing $414,000.00 to Lewis & Clark College from August 1, 2024 to July 31, 2027 to investigate the role of lipid metabolism in the biogenesis of lysosome-related organelles (LROs). The research aims to gain a better understanding of the processes controlling LRO morphology by studying the ACDH-11 protein and its...
- Federal Project Grant Award Summary Oregon Health & Science University (OHSU) received a $394,214 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective July 1, 2025, through June 30, 2030. This award supports continuation of research investigating intracellular lipid transfer mechanisms, building upon prior funded work (R01 GM127631). The research centers on characterizing how...
- This $299,396 National Science Foundation project grant supports research into the role of lipids in modulating synaptic plasticity of ion channels. Funded under the Biological Sciences program (CFDA 47.074), the two-year award to the University of Tennessee will elucidate the microscopic mechanisms involved in ion transport across membrane-associated protein channels. Researchers will focus on dynamic and structural features of biological membranes and leverage non-invasive scattering...
- This $342,934.65 project grant from the Department of Health and Human Services National Institutes of Health National Institute on Aging, under the Aging Research program (CFDA 93.866), will fund research into acyl chain remodeling and regional lipid dysregulation in Alzheimer's disease. The Trustees of Columbia University in the City of New York, doing business as Health Sciences Division, will analyze lipid composition in brain regions susceptible to Alzheimer's disease, such as the...
- Federal Project Grant Award Summary The Ohio State University received a $157,500 Project Grant from the National Center for Advancing Translational Sciences (NCATS, CFDA 93.350) awarded June 15, 2025, with a completion date of June 14, 2026. The award supports physiological characterization of Chloride Intracellular Channel 2 (CLIC2), an understudied ion channel implicated in X-linked intellectual disability and hypertrophic cardiomyopathy. The research addresses a significant knowledge gap, as...
- This $484,625 project grant, awarded on May 1, 2025 by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), supports fundamental scientific research on the spatiotemporal regulation of organelle interactions and metabolism. The research aims to provide a mechanistic understanding of lipid metabolism, particularly the role of lipid droplets in metabolic diseases like insulin resistance, obesity, and...
- This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $657,308 to The Children's Hospital of Philadelphia (CHOP) to conduct research on the CXCL12 signaling axis and its role in pulmonary arterial heterogeneity, development, and disease. The key objectives of this 12-month project are to: 1) define the spatiotemporal role of CXCL12 signaling in pulmonary vascular development, 2)...
- Federal Grant Award Summary Vanderbilt University Medical Center received a $1.43 million Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) awarded May 5, 2025, with a completion date of February 28, 2030. The award supports a five-year research initiative investigating the structural biology and functional genomics of phospholipids and inositol phosphates within the cell nucleus—molecular...
- Federal Project Grant Award Summary The Children's Hospital of Philadelphia Research Institute received a $178,000 Project Grant from the National Center for Advancing Translational Sciences (NCATS, CFDA 93.350) awarded August 1, 2025, with completion targeted for July 31, 2026. This award supports research to elucidate the localization and functional role of SLC24A5 (which encodes the protein NCKX5) in skin pigmentation pathways. The project addresses significant gaps in understanding how...
DECIPHERING THE ROLE OF PHOSPHOLIPID HOMEOSTASIS IN PHYSIOLOGY AND DISEASE - PROJECT SUMMARY CHOLINE IS A VITAMIN-LIKE METABOLITE THAT IS INDISPENSABLE FOR CELLULAR AND ORGANISMAL VIABILITY WHICH MUST BE OBTAINED THROUGH DIET. ONCE IMPORTED INTO THE CELL, CHOLINE HAS MULTIPLE METABOLIC FATES INFLUENCING DIVERSE CELLULAR PROCESSES RANGING FROM MEMBRANE BIOSYNTHESIS TO EPIGENETICS. CHOLINE IT IS A KEY CONSTITUENT OF PHOSPHOLIPIDS, ACETYLCHOLINE, AND BETAINE WHICH IN TURN IMPACTS S-ADENOSYLMETHIONINE (SAM) AND DNA METHYLATION. DESPITE THE INFLUENCE OF CHOLINE ON DIVERSE CELLULAR PROCESSES, THE IDENTITY OF A HIGH AFFINITY CHOLINE TRANSPORTER UBIQUITOUSLY EXPRESSED ACROSS MAMMALIAN TISSUES WAS UNKNOWN. IN OUR RECENTLY PUBLISHED PRELIMINARY DATA, WE UTILIZED GENOME-WIDE ASSOCIATION STUDIES (GWAS) OF SERUM METABOLITES TO IDENTIFY A POORLY CHARACTERIZED PLASMA MEMBRANE PROTEIN, FELINE LEUKEMIA VIRUS SUBGROUP C CELLULAR RECEPTOR 1 (FLVCR1), AS THE PREDOMINANT CHOLINE TRANSPORTER IN MAMMALS. IN HUMAN CELLS AND THE DEVELOPING MOUSE EMBRYO, FLVCR1 LOSS SEVERELY IMPACTS CHOLINE METABOLISM RESULTING IN DEPLETION OF BETAINE AND PHOSPHATIDYLCHOLINE (PC) - THE PREDOMINANT PHOSPHOLIPID SPECIES IN CELLULAR AND ORGANELLAR MEMBRANES. MECHANISTICALLY, FLVCR1 DIRECTLY TRANSPORTS CHOLINE INTO CELLS AND WE HAVE RECENTLY USED CRYOEM TO IDENTIFY THE RESIDUE NECESSARY FOR TRANSPORT. IN THIS EFFORT, WE ALSO DISCOVERED THAT FLVCR1 CAN ALSO TRANSPORT ETHANOLAMINE, SUGGESTING THAT IT MAY ALSO AFFECT PHOSPHATIDYLETHANOLAMINE (PE) SYNTHESIS, THE SECOND MOST ABUNDANT MEMBRANE PHOSPHOLIPID. TAKEN TOGETHER, THESE DATA SUGGEST THAT FLVCR1 IS A CRUCIAL TRANSPORTER FOR PHOSPHOLIPID METABOLISM. BROADLY, THIS PROPOSAL SEEKS TO INVESTIGATE THE INFLUENCE OF PHOSPHOLIPID METABOLISM ON CELLULAR AND ORGANISMAL PHYSIOLOGY. UTILIZING A CONDITIONAL KNOCKOUT MOUSE, IN AIM 1, WE WILL STUDY THE ROLE OF FLVCR1 IN ORGANISMAL PHYSIOLOGY AND METABOLISM AND ASSESS THE EFFICACY OF FLVCR1 AS A TARGET IN METABOLIC DISEASE. OUR PRELIMINARY DATA SUGGEST THAT MITOCHONDRIAL STRESS AND ACTIVATION OF THE INTEGRATED STRESS RESPONSE ARE DEFINING FEATURES OF CELLS AND EMBRYOS LACKING FLVCR1. IN AIM 2 WE WILL STUDY HOW FLVCR1 LOSS AND PHOSPHOLIPID METABOLISM IMPACTS MITOCHONDRIAL FUNCTION AND THE SUBSEQUENT CELLULAR STRESS RESPONSE. IN AIM 3 WE SEEK TO UNDERSTAND HOW PHOSPHOLIPID HOMEOSTASIS IS MAINTAINED AND REGULATED. SPANNING BASIC BIOCHEMISTRY TO MOUSE MODELING, THIS APPLICATION WILL ADDRESS OUTSTANDING FUNDAMENTAL QUESTIONS IN CELLULAR METABOLISM AND SEEK TO APPLY THESE FINDINGS TO THE POSSIBLE TREATMENT OF HUMAN DISEASE. THE INNOVATIVE STUDIES PROPOSED IN THIS APPLICATION IN ADDITION TO THE PERSONALIZED TRAINING PLAN, WILL PROVIDE RIGOROUS SCIENTIFIC TRAINING AND PROFESSIONAL DEVELOPMENT WHICH WILL ENABLE MY TRANSITION TO INDEPENDENCE AND START MY OWN LABORATORY AS A TENURE-TRACK PROFESSOR.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $90.0k | 6/3/25 | ||
| Not listed | $91.5k | 7/16/24 | ||
| Not listed | $91.5k | 7/16/24 |